Estrogen opposes the apoptotic effects of bone morphogenetic protein 7 on tissue remodeling

Molecular and Cellular Biology

Volumn 20, Issue 13, 2000, Pages 4626-4634

  Monroe, David G ^a   Jin, Donald F ^b   Sanders, Michel M ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b CURIS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; OSTEOGENIC PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ESTROGEN ACTIVITY; ESTROGEN BLOOD LEVEL; ESTROGEN THERAPY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OVARY CYCLE; OVIDUCT; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; BASE SEQUENCE; BONE MORPHOGENETIC PROTEINS; CELLS, CULTURED; CHICKENS; ESTRADIOL; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; MOLECULAR SEQUENCE DATA; OVIDUCTS; RNA, MESSENGER; SEQUENCE HOMOLOGY, AMINO ACID; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 0034083152     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.20.13.4626-4634.2000     Document Type: Article

References (76)

1. Arends, M. J., R. G. Morris, and A. H. Wyllie. 1990. Apoptosis: the role of the endonuclease. Am. J. Pathol. 136:593-608.
2. Arkell, R., and R. S. P. Beddington. 1997. BMP-7 influences pattern and growth of the developing hindbrain of mouse embryos. Development 124: 1-12.
3. Berger, R. R., and M. M. Sanders. 2000. Estrogen modulates HNF-3β mRNA levels in the developing oviduct. DNA Cell Biol. 19:103-112.
4. Herman, J. R., M. M. McCarthy, and N. Kyprianou. 1998. Effect of estrogen withdrawal on nitric oxide synthase expression and apoptosis in the rat vagina. Urology 51:650-655.
5. Brodin, G., P. ten Dijke, K. Funa, C.-H. Heldin, and M. Landstrom. 1999. Increased Smad expression and activation are associated with apoptosis in normal and malignant prostate after castration. Cancer Res. 59:2731-2738.
6. Carr, B. R. 1992. Disorders of the ovary and female reproductive tract, 8th ed. W. B. Saunders Company, Philadelphia, Pa.
7. Chamberlain, E. M., and M. M. Sanders. 1999. Identification of the novel player δEF1 in estrogen transcriptional cascades. Mol. Cell. Biol. 19:3600-3606.
8. Cohrs, R., B. B. Goswami, and O. K. Sharma. 1988. Occurrence of 2-5A and RNA degradation in the chick oviduct during rapid estrogen withdrawal. Biochemistry 27:3246-3252.
9. Cohrs, R. J., B. B. Goswami, and O. K. Sharma. 1988. Down regulation of c-myc, c-fos and erb-B during estrogen induced proliferation of the chick oviduct. Biochem. Biophys. Res. Commun. 150:82-88.
10. Detre, S., J. Salter, U. M. Barnes, S. Riddler, M. Hills, S. R. D. Johnston, C. Gillett, R. A'Hern, and M. Dowsett. 1999. Time-related effects of estrogen withdrawal on proliferation and cell death-related events in MCF-7 xenografts. Int. J. Cancer 81:309-313.
11. Fitzgerald, M., and T. Schenk. 1981. The sequence 5′-AAUAAA-3′ forms part of the recognition sequence for polyadenylation of late SV40 mRNAs. Cell 24:251-260.
12. Galien, R., and T. Garcia. 1997. Estrogen receptor impairs interleukin-6 expression by preventing protein binding on the NF-κΒ site. Nucleic Acids Res. 25:2424-2429.
13. Gavrieli, Y., Y. Sherman, and S. A. Ben-Sasson. 1992. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119:493-501.
14. Glozak, M. A., and M. B. Rogers. 1996. Specific induction of apoptosis in P19 embryonal carcinoma cells by retinoic acid and BMP2 or BMP4. Dev. Biol. (Orlando) 179:458-470.
15. Gold, L. I., and T. V. Parekh. 1999. Loss of growth regulation by transforming growth factor-β (TGF-β) in human cancers: studies on endometrial carcinoma. Semin. Reprod. Endocrinol. 17:73-92.
16. Gong, J., F. Traganos, and Z. Darzynkiewicz. 1994. A selective procedure for DNA extraction from apoptotic cells applicable for gel electrophoresis and flow cytometry. Anal. Biochem. 218:314-319.
17. Harada, S., T. K. Sampath, J. E. Aubin, and G. A. Rodan. 1997. Osteogenic protein-1 up-regulation of the collagen X promoter activity is mediated by a MEF-2-like sequence and requires an adjacent AP-1 sequence. Mol. Endocrinol. 11:1832-1845.
18. Hazama, M., A. Aono, N. Ueno, and Y. Fujisawa. 1995. Efficient expression of a heterodimer of bone morphogenetic protein subunits using a baculovirus expression system. Biochem. Biophys. Res. Commun. 209:859-866.
19. Helder, M. N., A. Karg, T. J. M. Bervoets, S. Vukicevic, E. H. Burger, R. N. D'Souza, J. H. M. Woltgens, G. Karsenty, and A. L. J. J. Bronckers. 1998. Bone morphogenetic protein-7 (osteogenic protein-1, OP-1) and tooth development. J. Dent. Res. 77:545-554.
20. Hermoso, M., J. C. Saez, and M. Villalon. 1997. Identification of gap junctions in the oviduct and regulation of connexins during development and by sexual hormones. Eur. J. Cell Biol. 74:1-9.
21. Heryanto, B., Y. Yoshimura, T. Tamura, and T. Okamoto. 1997. Involvement of apoptosis and lysosomal hydrolase activity in the oviducal regression during induced molting in chickens: a cytochemical study for end labeling of fragmented DNA and acid phosphatase. Poultry Sci. 76:67-72.
22. Hogan, B. L. M. 1996. Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev. 10:1580-1594.
23. Houston, B., B. H. Thorpe, and D. W. Hurt. 1994. Molecular cloning and expression of bone morphogenetic protein-7 in the chick epiphyseal growth plate. J. Mol. Endocrinol. 13:289-301.
24. L and adenovirus protein E1B19kD are functionally equivalent in their ability to inhibit cell death. Oncogene 14:405-414.
25. Huet-Hudson, Y. M., C. Chakraborty, S. K. De, Y. Suzuki, G. K. Andrews, and S. K. Dey. 1990. Estrogen regulates the synthesis of epidermal growth factor in mouse uterine epithelial cells. Mol. Endocrinol. 4:510-523.
26. Ignar-Trowbridge, D. M., M. Pimentel, C. T. Teng, K. S. Korach, and J. A. McLachlan. 1995. Cross talk between peptide growth factor and estrogen receptor signaling systems. Environ. Health Perspect. 103:35-38.
27. Jaffe, R. C., E. B. Arias, M. B. O'Day-Bowman, K. M. Donnelly, P. A. Mavrogianis, and H. G. Verhage. 1996. Regional distribution and hormone control of estrogen-dependent oviduct-specific glycoprotein messenger ribonucleic acid in the baboon (Papio anubis). Biol. Reprod. 55:421-426.
28. Jena, N., C. Martin-Seisdedos, P. McCue, and C. M. Croce. 1997. BMP7 null mutation in mice: developmental defects in skeleton, kidney, and eye. Exp. Cell Res. 230:28-37.
29. Kepa, J. K., C. I. Neely, B. M. Jacobsen, J. M. Bruder, D. P. McDonnell, K. K. Leslie, and M. E. Wierman. 1994. Estrogen receptor mediated repression of rat gonadotropin releasing hormone (GnRH) promoter activity in hypothalamic cells. Endocr. Rev. 2:1-10.
30. Keri, R. A., B. Andesen, G. C. Kennedy, D. L. Hamernik, C. M. Clay, A. D. Brace, T. M. Nett, A. C. Notides, and J. H. Nilson. 1991. Estradiol inhibits transcription of the human glycoprotein hormone α-subunit despite the absence of a high affinity binding site for estrogen receptor. Mol. Endocrinol. 5:725-733.
31. Kurebayashi, S., Y. Miyashita, T. Hirose, S. Kasayama, S. Akira, and T. Kishimoto. 1997. Characterization of mechanisms of interleukin-6 repression by estrogen receptor. J. Steroid Biochem. Mol. Biol. 60:11-17.
32. Kyprianou, N., and J. T. Isaacs. 1988. Activation of programmed cell death in the rat ventral prostate after castration. Endocrinology 122:552-562.
33. Lincz, L. F. 1998. Deciphering the apoptotic pathway: all roads lead to death. Immunol. Cell Biol. 76:1-19.
34. Llen, R. T., W. J. Hunter 3rd, and D. K. Agrawal. 1997. Morphological and biochemical characterization and analysis of apoptosis. J. Pharmacol. Toxicol. Methods 37:215-228.
35. Loo, D. T., and J. R. Rillema. 1998. Measurement of cell death. Methods Cell Biol. 57:251-264.
36. Luo, G., C. Hofmann, A. L. J. J. Bronckers, M. Sohocki, A. Bradley, and G. Karsenty. 1995. BMP-7 in an inducer of nephrogenesis, and is also required for eye development and skeletal patterning. Genes Dev. 9:2808-2820.
37. Macias, D., Y. Ganan, T. K. Sampath, M. E. Piedra, M. A. Ros, and J. M. Hurle. 1997. Role of BMP2 and OP-1 (BMP-7) in programmed cell death and skeletogenesis during chick limb development. Development 124:1109-1117.
38. Macias-Silva, M., P. A. Hoodless, S. J. Tang, M. Buchwald, and J. L. Wrana. 1998. Specific activation of Smad1 signaling pathways by the BMP7 type 1 receptor, ALK2. J. Biol. Chem. 273:25628-25636.
39. Malayer, J. R., and J. Gorski. 1993. An integrated model of estrogen receptor action. Domest. Anim. Endocrinol. 10:159-177.
40. Malayer, J. R., and V. M. Woods. 1998. Expression of estrogen receptor and maintenance of hormone-responsive phenotype in bovine fetal uterine cells. Domest. Anim. Endocrinol. 15:141-154.
41. McLachlan, J. A., K. G. Nelson, T. Takahashi, N. L. Bossert, R. R. Newbold, and K. S. Korach. 1991. Estrogens and growth factors in the development, growth, and function of the female reproductive tract. Springer-Verlag, New York, N.Y.
42. Medema, J. P., C. Scaffidi, F. C. Kischkel, A. Shevchenko, M. Mann, P. H. Krammer, and M. E. Peter. 1997. FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J. 16:2794-2804.
43. Miller, C. D., and W. L. Miller. 1996. Transcriptional repression of the ovine follicle-stimulating hormone-β gene by 17β-estradiol. Endocrinology 137: 3437-3446.
44. Murphy, L. J., L. C. Murphy, and H. G. Friesen. 1987. Estrogen induces insulin-like growth factor-I expression in the rat uterus. Mol. Endocrinol. 1:445-450.
45. Nelson, K. G., T. Takahashi, D. C. Lee, N. C. Luetteke, N. L. Bossert, K. Ross, B. E. Eitzman, and J. A. McLachlan. 1992. Transforming growth factor-α is a potential mediator of estrogen action in the mouse uterus. Endocrinology 131:1657-1664.
46. Newmeyer, D. D., D. M. Farschon, and J. C. Reed. 1994. Cell-free apoptosis in Xenopus egg extracts: inhibition by Bcl-2 and requirement for an organelle fraction enriched in mitochondria. Cell 79:353-364.
47. Nordstrom, L. A., D. M. Dean, and M. M. Sanders. 1993. A complex array of double-stranded and single-stranded DNA-binding proteins mediates induction of the ovalbumin gene by steroid hormones. J. Biol. Chem. 268: 13193-13202.
48. Nunez, G., M. A. Benedict, Y. Hu, and N. Inohara. 1998. Caspases: the proteases of the apoptotic pathway. Oncogene 17:3237-3245.
49. Ozkaynak, E., D. F. Jin, M. Jelic, S. Vukicevic, and H. Oppermann. 1997. Osteogenic protein-1 mRNA in the uterine endometrium. Biochem. Biophys. Res. Commun. 234:242-246.
50. Ozkaynak, E., D. C. Rueger, E. A. Drier, C. Corbett, R. J. Ridge, T. K. Sampath, and H. Oppermann. 1990. OP-1 cDNA encodes an osteogenic protein in the TGF-β family. EMBO J. 9:2085-2093.
51. Ozkaynak, E., P. N. J. Schnegelsberg, and H. Oppermann. 1991. Murine Osteogenic protein (OP-1): high levels of mRNA in kidney. Biochem. Biophys. Res. Commun. 179:116-123.
52. Porter, A. G., and R. U. Janicke. 1999. Emerging roles of caspase-3 in apoptosis. Cell Death Differ. 6:99-104.
53. Ray, P., S. K. Ghosh, D.-H. Zhang, and A. Ray. 1997. Repression of interleukin-6 gene expression by 17β-estradiol: inhibition of the DNA-binding activity of the transcription factors NF-IL6 and NF-κΒ by the estrogen receptor. FEBS Lett. 409:79-85.
54. Reinhardt, K. C., R. K. Dubey, C. L. Mummery, M. van Rooijn, P. J. Keller, and R. Marinella. 1998. Synthesis and regulation of leukaemia inhibitory factor in cultured bovine oviduct cells by hormones. Mol. Human Reprod. 4:301-308.
55. Reiss, M., and M. H. Barcellos-Hoff. 1997. Transforming growth factor-β in breast cancer: a working hypothesis. Breast Cancer Res. Treat. 45:81-95.
56. Rochwerger, L., and M. Buchwald. 1993. Stimulation of the cystic hhrosis transmembrane regulator expression by estrogen in vivo. Endocrinology 133: 921-930.
57. Russo, M. A., V. Guerriero, and A. R. Means. 1987. Hormonal regulation of a chicken oviduct messenger ribonucleic acid that shares a common domain with gizzard myosin light chain kinase. Mol. Endocrinol. 1:60-67.
58. Sampath, T. K., J. E. Coughlin, R. M. Whetstone, D. Banach, C. Corbett, R. J. Ridge, E. Ozkaynak, H. Oppermann, and R. C. Rueger. 1990. Bovine osteogenic protein is composed of dimers of OP-1 and BMP-2A, two members of the transforming growth factor-β superfamily. J. Biol. Chem. 265: 13198-13205.
59. Sampath, T. K., J. C. Maliakal, P. V. Hauschka, W. K. Jones, H. Sasak, R. F. Tucker, K. H. White, J. E. Coughlin, M. M. Tucker, R. H. L. Pang, C. Corbett, E. Ozkaynak, H. Oppermann, and D. C. Rueger. 1992. Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. J. Biol. Chem. 267:20352-20362.
60. Sampath, T. K., and A. H. Reddi. 1981. Dissociative extraction and reconstitution of extracellular matrix components involved in local bone differentiation. Proc. Natl. Acad. Sci. USA 78:7599-7603.
61. Sanders, M. M., and G. S. McKnight. 1985. Chicken egg white genes: multihormonal regulation in a primary cell culture system. Endocrinology 116:398-405.
62. Sanders, M. M., and G. S. McKnight. 1988. Positive and negative regulatory elements control the steroid-responsive ovalbumin promoter. Biochemistry 27:6550-6557.
63. Schell, D. L., P. A. Mavrogianis, A. T. Fazleabas, and H. G. Verhage. 1994. Epidermal growth factor, transforming growth factor-alpha, and epidermal growth factor receptor localization in the baboon (Papio anubis) oviduct during steroid treatment and the menstrual cycle. J. Soc. Gynecol. Investig. 1:269-276.
64. Shepherd, J. H., E. R. Mulvihill, P. S. Thomas, and R. D. Palmiter. 1980. Commitment of chick oviduct tubular gland cells to produce ovalbumin mRNA during hormonal withdrawal and restimulation. J. Cell Biol. 87:142-151.
65. Shoham, Z., and M. Schachter. 1996. Estrogen biosynthesis-regulation, action, remote effects, and value of monitoring in ovarian stimulation cycles. Fertility Sterility 65:687-701.
66. Smale, S. T. 1997. Transcription initiation from TATA-less promoters within eukaryotic protein-coding genes. Biochim. Biophys. Acta 1351:73-88.
67. Smith, C. L. 1998. Cross-talk between peptide growth factor and estrogen signaling pathways. Biol. Reprod. 58:627-632.
68. Takahashi, T., B. Eitzman, N. L. Bossert, D. Walmer, K. Sparrow, K. C. Flanders, J. McLachlan, and K. G. Nelson. 1994. Transforming growth factors β1, β2, and β3 messenger RNA and protein expression in mouse uterus and vagina during estrogen-induced growth: a comparison to other estrogen-regulated genes. Cell Growth Differ. 5:919-935.
69. Tanabe, Y., T. Ogawa, and T. Nakamura. 1981. The effect of short term starvation on pituitary and plasma LH, plasma estradiol and progesterone, and on pituitary response to LH-RH in the laying hens. Gen. Comp. Endocrinol. 43:392-398.
70. Tang, S. G., P. A. Hoodless, Z. Lu, M. L. Breitman, R. R. McInnes, J. L. Wrana, and M. Buchwald. 1998. The Tlx-2 homeobox gene is a downstream target of BMP signaling and is required for mouse mesoderm development. Development 125:1877-1887.
71. Thomas, R., W. A. Anderson, V. Raman, and A. H. Reddi. 1998. Androgen-dependent gene expression of bone morphogenetic protein 7 in mouse prostate. Prostate 37:236-245.
72. Tomkinson, A., J. Reeve, R. W. Shaw, and B. S. Noble. 1997. The death of osteocytes via apoptosis accompanies estrogen withdrawal in human bone. J. Clin. Endocrinol. Methods 82:3128-3135.
73. Urist, M. R. 1965. Bone: formation by autoinduction. Science 150:893-899.
74. Volk, S. W., P. Luvalle, T. Leask, and P. S. LeBoy. 1998. A BMP responsive transcriptional region in the chicken type X collagen gene. J. Bone Miner. Res. 13:1521-1529.
75. Wada, K., S. Nomura, E. Morii, Y. Kitamura, Y. Nishizawa, A. Miyake, and N. Terada. 1996. Changes in levels of mRNAs of transforming growth factor (TGF)-β1, -β2, -β3, TGF-β type II receptor and sulfated glycoprotein-2 during apoptosis of mouse uterine epithelium. J. Steroid Biochem. Mol. Biol. 59:367-375.
76. Wang, S., M. Krinks, L. Kleinwaks, and J. M. Moos. 1997. A novel Xenopus homologue of bone morphogenetic protein-7 (BMP-7). Genes Function 1:259-271.